Cargando…

Gut Microbiota Changes in Patients With Major Depressive Disorder Treated With Vortioxetine

Vortioxetine hydrobromide is a common clinical medication for major depressive disorder (MDD). However, it remains unclear whether vortioxetine hydrobromide acts by affecting the structure and composition of gut microbiota. Here, we analyzed fecal samples from 28 healthy controls (HCs) and 26 patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Xiaolin, Wang, Dong, Zhu, Huaqian, Wang, Dahai, Li, Jing, Tang, Yanqing, Wu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138160/ https://www.ncbi.nlm.nih.gov/pubmed/34025474 http://dx.doi.org/10.3389/fpsyt.2021.641491

Ejemplares similares

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults
por: Zhang, Xinyan, et al.
Publicado: (2022)

Vortioxetine Modulates the Regional Signal in First-Episode Drug-Free Major Depressive Disorder at Rest
por: Xiong, Shihong, et al.
Publicado: (2022)

Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
por: Mattingly, Gregory W., et al.
Publicado: (2022)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
por: Bennabi, Djamila, et al.
Publicado: (2019)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea
por: Moon, Seok Woo, et al.
Publicado: (2023)

Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study
por: Mattingly, Gregory, et al.
Publicado: (2023)

Systematic Review of Gut Microbiota and Major Depression
por: Cheung, Stephanie G., et al.
Publicado: (2019)

Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
por: Segura-Garcia, Cristina, et al.
Publicado: (2021)

Efficacy of vortioxetine on the physical symptoms of major depressive disorder
por: Christensen, Michael Cronquist, et al.
Publicado: (2018)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Effects of Vortioxetine on Sleep Architecture of Adolescents with Major Depressive Disorder
por: Mlyncekova, Zuzana, et al.
Publicado: (2023)

Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality
por: Zhang, Qi, et al.
Publicado: (2021)

Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder
por: Horne, Rachael, et al.
Publicado: (2018)

Major depression with musical obsession treated with vortioxetine: a case report
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Disrupted Regional Homogeneity in Major Depressive Disorder With Gastrointestinal Symptoms at Rest
por: Yan, Meiqi, et al.
Publicado: (2021)

Gender differences in major depressive disorders: A resting state fMRI study
por: Tu, Zhaoyuan, et al.
Publicado: (2022)

The role of leptin in indirectly mediating “somatic anxiety” symptoms in major depressive disorder
por: Zhu, Yue, et al.
Publicado: (2022)

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
por: Florea, Ioana, et al.
Publicado: (2017)

Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder
por: Song, Yanzhuo, et al.
Publicado: (2022)

Disrupted Regional Homogeneity in Melancholic and Non-melancholic Major Depressive Disorder at Rest
por: Yan, Meiqi, et al.
Publicado: (2021)

Structural and Functional Abnormities of Amygdala and Prefrontal Cortex in Major Depressive Disorder With Suicide Attempts
por: Wang, Lifei, et al.
Publicado: (2020)

New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
por: Katona, Cornelius L, et al.
Publicado: (2014)

Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature
por: Kelliny, Marc, et al.
Publicado: (2015)

Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder
por: Dong, Zaiquan, et al.
Publicado: (2021)

The aberrant dynamic amplitude of low-frequency fluctuations in melancholic major depressive disorder with insomnia
por: Deng, Zijing, et al.
Publicado: (2022)

The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhu, Yue, et al.
Publicado: (2019)

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

The roles of extracellular vesicles in major depressive disorder
por: Li, Ying, et al.
Publicado: (2023)

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
por: Papalexi, Eugenia, et al.
Publicado: (2022)

Potential roles of the gut microbiota in the manifestations of drug use disorders
por: Wang, Zhiyan, et al.
Publicado: (2022)

Age-specific differential changes on gut microbiota composition in patients with major depressive disorder
por: Chen, Jian-Jun, et al.
Publicado: (2020)

The Gut Microbiota and Associated Metabolites Are Altered in Sleep Disorder of Children With Autism Spectrum Disorders
por: Hua, Xueying, et al.
Publicado: (2020)

Altered gut microbiota profile in patients with perimenopausal panic disorder
por: Lin, Shen, et al.
Publicado: (2023)

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
por: McIntyre, Roger S., et al.
Publicado: (2020)

Altered Composition of Gut Microbiota in Depression: A Systematic Review
por: Barandouzi, Zahra Amirkhanzadeh, et al.
Publicado: (2020)

Histamine and histamine receptors: Roles in major depressive disorder
por: Qian, Hong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rdhsuuopmd8fergkj1vv8vh5d3